Relay Therapeutics Balance Sheet
NASDAQ: RLAYHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Relay Therapeutics financial position
At the end of fiscal 2025, Relay Therapeutics reported total assets of $621.3 million, down 28.7% from a year earlier against total liabilities of $54.3 million. Shareholders' equity stood at $567.1 million, or 91.3% of assets. The company held $84.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 22.61, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Relay Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 84.02M | 124.29M | 143.74M | 151.79M | 280.12M | 447.65M | 41.95M |
| Receivables | — | — | — | 306.00K | 403.00K | 75.00M | — |
| Total Current Assets | 578.28M | 809.20M | 770.10M | 1.02B | 976.24M | 770.10M | 360.54M |
| Property, Plant & Equipment | 1.73M | 5.91M | 10.90M | 11.63M | 6.54M | 6.25M | 8.09M |
| Intangible Assets | — | — | 2.30M | 2.30M | 2.30M | — | — |
| Total Assets | 621.33M | 871.30M | 843.98M | 1.10B | 1.01B | 799.83M | 393.07M |
| Accounts Payable | 7.71M | 14.10M | 9.21M | 10.58M | 8.28M | 6.35M | 6.99M |
| Total Current Liabilities | 25.58M | 50.73M | 30.27M | 63.71M | 24.32M | 13.63M | 11.99M |
| Total Liabilities | 54.27M | 93.50M | 91.98M | 149.55M | 110.64M | 36.54M | 35.73M |
| Shareholders' Equity | 567.06M | 777.79M | 752.00M | 950.22M | 897.81M | 763.29M | -180.44M |
| Retained Earnings | -2.01B | -1.74B | -1.40B | -1.06B | -768.10M | -404.23M | -189.48M |
| Net Cash (Debt) | 84.02M | 124.29M | 143.74M | 151.79M | 280.12M | 447.65M | 41.95M |
| Shares Outstanding | 173.87M | 167.76M | 127.46M | 121.11M | 108.21M | 89.91M | 4.04M |
This table shows 7 annual periods of Relay Therapeutics's balance sheet, from FY 2025 back to FY 2019, across 13 line items including cash & equivalents, receivables, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow RLAY's reporting calendar. What is a balance sheet?